Candida Albicans
/api/v1/drug/candida-albicansMechanism of action
Sourced from openFDAMechanism-of-action classes: Adrenergic beta-Antagonists; Immunologic Factor Interactions.
Indications
Sourced from openFDA- For temporary relief of gas with abdominal discomfort after eating, mood swings, joint pains, irritability, forgetfulness, skin rashes, and fatigue.
Dosage & administration
Sourced from openFDADIRECTIONS: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Warnings & precautions
Sourced from openFDAIf pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place.
FAERS reports
- 1Fatigue887.7%
- 2Diarrhoea817.1%
- 3Nausea766.6%
- 4Pain746.4%
- 5Headache736.4%
- 6Dizziness625.4%
- 7Drug Ineffective554.8%
- 8Arthralgia534.6%
- 9Urinary Tract Infection494.3%
- 10Asthenia484.2%
- 11Off Label Use474.1%
- 12Constipation464.0%
- 13Fall464.0%
- 14Malaise443.8%
- 15Vomiting433.7%
Literature
Recent PubMed references pinned to Candida Albicans as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Quadratic Concentration-Response Modeling and Molecular Docking of Mespilodaphne quixos (Lam.) Rohwer Essential Oil Against Candida albicans.Molecules (Basel, Switzerland) · 2026 · Arteaga-Crespo Y, García-Quintana Y, Velásquez López Y, et al.PMID 42280194DOI 10.3390/molecules31111891
- Hydrocinnamic Acid From Candida albicans: Isolation, Characterization, and Antibacterial Activity Against Multidrug-Resistant Bacteria.Biomedical chromatography : BMC · 2026 · Kaviraj M, Jayappriyan KR, Raja R, et al.PMID 42252724DOI 10.1002/bmc.70505
- Evaluation of Adhesion and Co-culture Efficacy Assays of Antifungals and Chlorhexidine Against Acanthamoeba and Candida Species Associated with Severe Infectious Keratitis.Current microbiology · 2026 · Matiola DC, da Rosa Monte Machado G, Israel GE, et al.PMID 42240844DOI 10.1007/s00284-026-04970-7
- Identification of efflux inhibitors through a drug repurposing strategy in Candida albicans.Frontiers in cellular and infection microbiology · 2026 · Marques D, Costa SS, Rodrigues L, et al.PMID 42233159DOI 10.3389/fcimb.2026.1798450
- Repurposing the antispasmodic drug pinaverium bromide as a novel antifungal agent and synergist against Candida albicans.Virulence · 2026 · Yao J, Yang Z, Hang X, et al.PMID 42226574DOI 10.1080/21505594.2026.2682573
- Chemical Composition and Antifungal Evaluation of Essential Oil From Fresh Leaves of Myrcia spectabilis DC Against Candida spp. and Pichia kudriavzevii.Chemistry & biodiversity · 2026 · Silva FDS, Silva LED, Amaral WD, et al.PMID 42216857DOI 10.1002/cbdv.71374
- Ergosterol-Dependent Membrane Stress and Calcineurin-HSP90 Signaling Govern Fluorinated Sulfone-Induced Cell Death in Candida albicans.Mycopathologia · 2026 · Staniszewska A, Kuryk Ł, Kala D, et al.PMID 42213245DOI 10.1007/s11046-026-01081-6
- In silico identification of isosilybin a targeting squalene epoxidase as an antifungal adjuvant with in vitro validation against azole-resistant Candida and emerging yeasts.Frontiers in cellular and infection microbiology · 2026 · Mundhe AK, Rajkumari RPMID 42205484DOI 10.3389/fcimb.2026.1774455
Clinical trials
The 10 most recently updated of 396 ClinicalTrials.gov registrations naming Candida Albicans as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Biological, Radiographic and Clinical Evaluation of Various Inter-Visit Root Canal Dressings in Retreatment CasesRecruiting · Phase 1 · Interventional · 60 enrolled · Ain Shams UniversityNCT07641933updated 2026-06-12
- Effect of Probiotics on Relapsing-Remitting Multiple SclerosisCompleted · Interventional · 60 enrolled · Cairo UniversityNCT07346924updated 2026-06-08
- Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKDActive not recruiting · Phase 2 · Interventional · 118 enrolled · University of Colorado, DenverNCT04040959updated 2026-06-05
- Large Algorithm Setting and Validation StudyNot yet recruiting · Observational · 1,000 enrolled · Nanopath, IncNCT07607470updated 2026-05-26
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.Recruiting · Phase 3 · Interventional · 450 enrolled · Basilea PharmaceuticaNCT05421858updated 2026-05-20
- Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel DiseaseRecruiting · Interventional · 40 enrolled · University of PadovaNCT07591012updated 2026-05-15
- Effects of UNICLA-A2 Dairy Products on Patients at High-risk of Colorectal Cancer DevelopmentRecruiting · Interventional · 34 enrolled · Instituto de Investigación Sanitaria AragónNCT04824053updated 2026-05-12
- Yeast Protein for Muscle MassNot yet recruiting · Phase 2 · Phase 3 · Interventional · 72 enrolled · University of AlbertaNCT07561619updated 2026-05-11
- A Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy AdultsCompleted · Interventional · 5 enrolled · KingdomNCT07547761updated 2026-05-11
- Saccharomyces Boulardii CNCM I-745 on Intestinal Barrier FunctionCompleted · Early phase 1 · Interventional · 56 enrolled · Mayo ClinicNCT05538247updated 2026-05-11
Frequently asked questions
- How does Candida Albicans work?
- Mechanism-of-action classes: Adrenergic beta-Antagonists; Immunologic Factor Interactions.
- What is Candida Albicans used for?
- According to FDA labeling, Candida Albicans carries indications including: For temporary relief of gas with abdominal discomfort after eating, mood swings, joint pains, irritability, forgetfulness, skin rashes, and fatigue.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Candida Albicans?
- Candida Albicans is classified as Non-Standardized Fungal Allergenic Extract, Adrenergic beta-Antagonists, Immunologic Factor Interactions, Cell-mediated Immunity, Increased Histamine Release, Increased IgG Production, Increased T Lymphocyte Activation.
candida-albicans is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.